Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up

European Journal of Pediatrics

Volumn 176, Issue 2, 2017, Pages 217-224

  Scalabrin, Dmf ^a   Harris, C ^a   Johnston, Wh ^b   Berseth, Cl ^a  

^a Clinical Research   (United States)

^b Birmingham Radiological Group PC   (United States)

Author keywords

Allergic manifestations; Children; Hydrolyzed formula; LGG; Probiotics

Indexed keywords

CASEIN HYDROLYSATE; PROBIOTIC AGENT; PROTEIN HYDROLYSATE; MILK PROTEIN;

ACUTE GASTROENTERITIS; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANTHROPOMETRY; ARTICLE; ARTIFICIAL MILK; ATOPIC DERMATITIS; BACTERIAL SKIN DISEASE; BEHAVIOR; BODY HEIGHT; BODY WEIGHT; BRONCHIOLITIS; BRONCHITIS; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CHILD SAFETY; COHORT ANALYSIS; COLITIS; CONJUNCTIVITIS; CONTACT DERMATITIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; FOOD ALLERGY; HEAD CIRCUMFERENCE; HUMAN; LACTOBACILLUS RHAMNOSUS; LARYNGITIS; MAJOR CLINICAL STUDY; MILK ALLERGY; MULTICENTER STUDY; OTITIS MEDIA; OUTCOME ASSESSMENT; PHARYNGITIS; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RHINITIS; RHINOCONJUNCTIVITIS; SEPSIS; SINUSITIS; SKIN INFECTION; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VIRAL SKIN DISEASE; WHEEZING; ANALYSIS; ANALYSIS OF VARIANCE; CHILD NUTRITION; INFANT; INFANT NUTRITION; MILK HYPERSENSITIVITY; NEWBORN;

ANALYSIS OF VARIANCE; CHILD NUTRITIONAL PHYSIOLOGICAL PHENOMENA; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; LACTOBACILLUS RHAMNOSUS; MILK HYPERSENSITIVITY; MILK PROTEINS;

EID: 85006152379     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-016-2825-4     Document Type: Article

References (55)

1. Sicherer SH, Sampson HA (2014) Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol 133:291–307 quiz 308
2. Gupta RS, Springston EE, Warrier MR, Smith B, Kumar R, Pongracic J, Holl JL (2011) The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics 128:e9–17
3. Host A, Halken S (2014) Cow’s milk allergy: where have we come from and where are we going? Endocr Metab Immune Disord Drug Targets 14:2–8
4. Sicherer SH, Noone SA, Munoz-Furlong A (2001) The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 87:461–464
5. Wood RA, Sicherer SH, Vickery BP, Jones SM, Liu AH, Fleischer DM, Henning AK, Mayer L, Burks AW, Grishin A et al (2013) The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol 131:805–812
6. Skripak JM, Matsui EC, Mudd K, Wood RA (2007) The natural history of IgE-mediated cow’s milk allergy. J Allergy Clin Immunol 120:1172–1177
7. Saarinen KM, Pelkonen AS, Makela MJ, Savilahti E (2005) Clinical course and prognosis of cow’s milk allergy are dependent on milk-specific IgE status. J Allergy Clin Immunol 116:869–875
8. Oldaeus G, Bradley CK, Bjorksten B, Kjellman NI (1992) Allergenicity screening of “hypoallergenic” milk-based formulas. J Allergy Clin Immunol 90:133–135
9. Koletzko S, Niggemann B, Arato A, Dias JA, Heuschkel R, Husby S, Mearin ML, Papadopoulou A, Ruemmele FM, Staiano A et al (2012) Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI committee practical guidelines. J Pediatr Gastroenterol Nutr 55:221–229
10. Fiocchi A, Brozek J, Schunemann H, Bahna SL, von Berg A, Beyer K, Bozzola M, Bradsher J, Compalati E, Ebisawa M et al (2010) World allergy organization (WAO) diagnosis and rationale for action against cow’s milk allergy (DRACMA) guidelines. Pediatr Allergy Immunol 21(Suppl 21):1–125
11. Muraro A, Hoekstra MO, Meijer Y, Lifschitz C, Wampler JL, Harris C, Scalabrin DM (2012) Extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG maintains hypoallergenic status: randomised double-blind, placebo-controlled crossover trial. BMJ Open 2:e000637
12. Sampson HA, Bernhisel-Broadbent J, Yang E, Scanlon SM (1991) Safety of casein hydrolysate formula in children with cow milk allergy. J Pediatr 118:520–525
13. Terheggen-Lagro SW, Khouw IM, Schaafsma A, Wauters EA (2002) Safety of a new extensively hydrolysed formula in children with cow’s milk protein allergy: a double blind crossover study. BMC Pediatr 2:10
14. Laitinen K, Kalliomaki M, Poussa T, Lagstrom H, Isolauri E (2005) Evaluation of diet and growth in children with and without atopic eczema: follow-up study from birth to 4 years. Br J Nutr 94:565–574
15. Christie L, Hine RJ, Parker JG, Burks W (2002) Food allergies in children affect nutrient intake and growth. J Am Diet Assoc 102:1648–1651
16. Isolauri E, Sutas Y, Makinen-Kiljunen S, Oja SS, Isosomppi R, Turjanmaa K (1995) Efficacy and safety of hydrolyzed cow milk and amino acid-derived formulas in infants with cow milk allergy. J Pediatr 127:550–557
17. Szajewska H, Chmielewska A (2013) Growth of infants fed formula supplemented with Bifidobacterium lactis Bb12 or Lactobacillus GG: a systematic review of randomized controlled trials. BMC Pediatr 13:185
18. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S et al (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514
19. Eloe-Fadrosh EA, Brady A, Crabtree J, Drabek EF, Ma B, Mahurkar A, Ravel J, Haverkamp M, Fiorino AM, Botelho C, et al. 2015: Functional dynamics of the gut microbiome in elderly people during probiotic consumption. MBio, 6
20. Petschow BW, Figueroa R, Harris CL, Beck LB, Ziegler E, Goldin B (2005) Effects of feeding an infant formula containing Lactobacillus GG on the colonization of the intestine: a dose-response study in healthy infants. J Clin Gastroenterol 39:786–790
21. Johnson-Henry KC, Donato KA, Shen-Tu G, Gordanpour M, Sherman PM (2008) Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun 76:1340–1348
22. Lebeer S, Claes I, Tytgat HL, Verhoeven TL, Marien E, von Ossowski I, Reunanen J, Palva A, Vos WM, Keersmaecker SC, Vanderleyden J (2012) Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol 78:185–193
23. Berni Canani R, Sangwan N, Stefka AT, Nocerino R, Paparo L, Aitoro R, Calignano A, Khan AA, Gilbert JA, Nagler CR 2015: Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J
24. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG (2012) Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307:1959–1969
25. Hao Q, Lu Z, Dong BR, Huang CQ, Wu T 2011: Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev:CD006895
26. Rautava S, Salminen S, Isolauri E (2009) Specific probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study. Br J Nutr 101:1722–1726
27. Szajewska H, Canani RB, Guarino A, Hojsak I, Indrio F, Kolacek S, Orel R, Shamir R, Vandenplas Y, van Goudoever JB, Weizman Z (2016) Probiotics for the prevention of antibiotic-associated diarrhea in children. J Pediatr Gastroenterol Nutr 62:495–506
28. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30:1604–1610
29. Kalliomaki M, Salminen S, Poussa T, Isolauri E (2007) Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 119:1019–1021
30. Berni Canani R, Nocerino R, Terrin G, Frediani T, Lucarelli S, Cosenza L, Passariello A, Leone L, Granata V, Di Costanzo M et al (2013) Formula selection for management of children with cow’s milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr 163:771–777 e771
31. Baldassarre ME, Laforgia N, Fanelli M, Laneve A, Grosso R, Lifschitz C (2010) Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. J Pediatr 156:397–401
32. Nermes M, Kantele JM, Atosuo TJ, Salminen S, Isolauri E (2011) Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin Exp Allergy 41:370–377
33. Thomas DW, Greer FR (2010) Probiotics and prebiotics in pediatrics. Pediatrics 126:1217–1231
34. Fiocchi A, Pawankar R, Cuello-Garcia C, Ahn K, Al-Hammadi S, Agarwal A, Beyer K, Burks W, Canonica GW, Ebisawa M et al (2015) World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): probiotics. World Allergy Organ J 8:4
35. Scalabrin DM, Johnston WH, Hoffman DR, P’Pool VL, Harris CL, Mitmesser SH (2009) Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial. Clin Pediatr (Phila) 48:734–744
36. Behrman RE, Kliegman RM, Jenson HB, Kliegman R, Jenson HB 2003: Nelson textbook of pediatrics. Table 10–4: emerging patterns of behavior during first year of life and table 11–1: emerging patterns of behavior from 1 to 5 yr of age. 17th edition. pp. 2672: Elsevier Health Sciences
37. Dupont C, Chouraqui JP, de Boissieu D, Bocquet A, Bresson JL, Briend A, Darmaun D, Frelut ML, Ghisolfi J, Girardet JP, et al. 2011: Dietary treatment of cows’ milk protein allergy in childhood: a commentary by the Committee on Nutrition of the French Society of Paediatrics. Br J Nutr:1–14
38. Rzehak P, Sausenthaler S, Koletzko S, Reinhardt D, von Berg A, Kramer U, Berdel D, Bollrath C, Grubl A, Bauer CP et al (2009) Short- and long-term effects of feeding hydrolyzed protein infant formulas on growth at < or = 6 y of age: results from the German infant nutritional intervention study. Am J Clin Nutr 89:1846–1856
39. Yan F, Polk DB (2012) GG: an updated strategy to use microbial products to promote health. Funct Food Rev 4:77–84
40. Cruchet S, Furnes R, Maruy A, Hebel E, Palacios J, Medina F, Ramirez N, Orsi M, Rondon L, Sdepanian V et al (2015) The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Paediatr Drugs 17:199–216
41. Salminen MK, Tynkkynen S, Rautelin H, Poussa T, Saxelin M, Ristola M, Valtonen V, Jarvinen A (2004) The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study. HIV Clin Trials 5:183–191
42. Manzoni P, Lista G, Gallo E, Marangione P, Priolo C, Fontana P, Guardione R, Farina D (2011) Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. Early Hum Dev 87(Suppl 1):S35–S38
43. Luoto R, Isolauri E, Lehtonen L (2010) Safety of Lactobacillus GG probiotic in infants with very low birth weight: twelve years of experience. Clin Infect Dis 50:1327–1328
44. Hibberd PL, Kleimola L, Fiorino AM, Botelho C, Haverkamp M, Andreyeva I, Poutsiaka D, Fraser C, Solano-Aguilar G, Snydman DR (2014) No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase I open label study to assess safety, tolerability and cytokine responses. PLoS One 9:e113456
45. Berni Canani R, Nocerino R, Terrin G, Coruzzo A, Cosenza L, Leone L, Troncone R 2012: Effect of Lactobacillus GG on tolerance acquisition in infants with cow’s milk allergy: a randomized trial. J Allergy Clin Immunol, 129:580–582, 582 e581–585
46. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R (2008) Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121:e850–e856
47. Douglas-Escobar M, Elliott E, Neu J (2013) Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr 167:374–379
48. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE (2006) Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6:374–382
49. Kvaerner KJ, Nafstad P, Jaakkola JJ (2000) Upper respiratory morbidity in preschool children: a cross-sectional study. Arch Otolaryngol Head Neck Surg 126:1201–1206
50. Li R, Dee D, Li CM, Hoffman HJ, Grummer-Strawn LM (2014) Breastfeeding and risk of infections at 6 years. Pediatrics 134(Suppl 1):S13–S20
51. Bruggink SC, Eekhof JA, Egberts PF, van Blijswijk SC, Assendelft WJ, Gussekloo J (2013) Warts transmitted in families and schools: a prospective cohort. Pediatrics 131:928–934
52. Kliegman RM, Stanton BF, Schor NF, St. Geme JW, Behrman RE 2011: Nelson textbook of pediatrics. 19 edn: Elsevier Saunders
53. Partty A, Luoto R, Kalliomaki M, Salminen S, Isolauri E (2013) Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 163:1272–1277 e1272
54. Partty A, Lehtonen L, Kalliomaki M, Salminen S, Isolauri E 2015: Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: a randomized, controlled trial. Pediatr Res
55. Partty A, Kalliomaki M, Wacklin P, Salminen S, Isolauri E 2015: A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res